Save time and get answers to complex questions with AI chat
Is clarinex off patent?Bivalirudin manufacturer?How to apply for vascepa's patient assistance?Tracleer online pharmacy?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?
See the DrugPatentWatch profile for praluent
Praluent (alirocumab) is an injection, not a pill. It's administered as a subcutaneous shot, typically every 2 or 4 weeks using a pre-filled pen or syringe.[1]
Patients self-inject Praluent into the abdomen, thigh, or upper arm. The 75 mg and 150 mg doses come in 1 mL pre-filled pens or syringes. No refrigeration is needed after first use; store at room temperature for up to 30 days.[1]
Praluent is a monoclonal antibody that targets PCSK9 to lower LDL cholesterol. Proteins like this degrade in the stomach, so injections deliver it directly into the bloodstream for effectiveness.[1][2]
Unlike daily pills such as statins (e.g., atorvastatin) or ezetimibe, Praluent requires fewer doses but needs injections. Statins are oral and cheaper generics; Praluent is for patients not controlled by pills alone.[1][2]
Other Questions About Praluent :